NORTH AMERICAN BUSINESS
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
NORTH AMERICAN BUSINESS
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
NORTH AMERICAN BUSINESS
No Result
View All Result
Home ALL Business Service

CellCarta acquires Biogazelle

by Ed Johnson
December 15, 2021
A A

CellCarta acquires Biogazelle to strengthen its genomic capabilities and expand into digital PCR (dPCR) services


This acquisition solidifies CellCarta’s leadership position in genomic services with a unique combination of assay development and global clinical trial sample analysis capabilities covering a comprehensive range of established and cutting-edge genomic technologies.        

MONTREAL, Canada, Dec 14, 2021 / CNW – CellCarta, a leading global provider of precision medicine laboratory services, announced today the acquisition of Biogazelle (“Biogazelle”), a leader in genomic testing solutions. Located in Ghent (Belgium), Biogazelle develops and deploys high-end digital PCR (dPCR), quantitative PCR (qPCR) and RNASeq assays for its pharmaceutical and biotech industry clients.

With decades of experience in gene expression analysis, the Biogazelle team is uniquely positioned and skilled in the application of quantitative PCR and digital PCR. Co-founders Jan Hellemans and Jo Vandesompele are internationally recognized for setting standards in gene expression analysis. Biogazelle, a Ghent University spin-off with the financial support of BNP Paribas Fortis and the investment funds of Qbic, PMV and the Fournier-Majoie Foundation, was the first European laboratory to offer the dPCR technology and is still at the forefront of dPCR-based research. The group also provides dedicated RNA sequencing workflows on clinical samples such as liquid biopsies and FFPE tissues.

“Biogazelle’s exceptional genomics expertise will enable CellCarta to further support its clients’ therapeutic development strategies, offering them key solutions to address their clinical challenges and move their immunology and other programs forward” said Martin LeBlanc, CEO of CellCarta. Acquiring Biogazelle strengthens CellCarta’s growth strategy to become the leading provider of precision medicine services and will allow the organization to extend genomic services from discovery to clinical settings. “We are very excited to join forces with CellCarta. With both organizations driven by scientific excellence and innovation, it’s the logical next step for us to maximally leverage our know-how and services on a truly global scale.” said Roel Sterken, CEO of Biogazelle.

While continuing to offer its current breadth of genomic services, Biogazelle will become CellCarta’s Center of Excellence for the development of complex genomic biomarker assays. The acquisition allows CellCarta to expand its offering to clients in fields with high demand in genomic analysis, such as immuno-oncology and cell and gene therapy.

Tags: < Invest | M&A
ShareTweetShareSend

Related Industries

Business Service

TÜV Rheinland North America completes the foundation of its new Technology and Innovation Center

April 13, 2023
Business Service

TÜV SÜD APPOINTS DR. FABIAN SCHOBER AS NEW CEO OF AMERICAS REGION

February 15, 2023
Business Service

Randstad announces new leaders for Asia Pacific, North America and Technologies business.

January 6, 2023
Business Service

Growth and Innovation Mark 10th Anniversary for Durham-Based Toshiba Global Commerce Solutions

August 25, 2022
Business Service

IBM and USTA Announce Multi-Year Partnership Renewal Ahead of 2022 US Open

August 19, 2022
Business Service

GE Digital’s Airspace Insight Now Features a Network View Module to Identify Opportunities to Improve Operational Performance

June 22, 2022

Harrington Process Solutions, a Leading Specialty Distributor of Flow Control Process Solutions, to be Acquired by Bain Capital Private Equity

September 8, 2023

...

Schneider Electric Unveils Latest Texas Manufacturing Plant as Part of a $300 Million Investment in U.S. Manufacturing

September 15, 2023

...

Daimler Truck North America Celebrates 15 Years of Successful Joint Venture with Bosch

September 20, 2023

...

Ford Launches Home Charging Pilot Program with Duke Energy for EV Customers to Save Money and Support Grid Sustainability

August 29, 2023

...

Intel, Tower Semiconductor logos

Intel Foundry Services and Tower Semiconductor Announce New US Foundry Agreement

September 6, 2023

...

Brillio Announces Investment by The Orogen Group

September 6, 2023

...

Soil Health Institute and Cargill Partner to Advance Water Stewardship Through Improved Soil Health

September 15, 2023

...

Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc.

September 20, 2023

...

Steamship Authority Electrifies Fleet with BYD – RIDE Zero-Emission Buses

September 26, 2023

...

NORTH AMERICAN BUSINESS (www.na-biz.com) is a leading source of business and corporate news, information, industry trends, market updates and insights across a broad spectrum of industries in North America and worldwide.

MENU

  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

CONTACT US

EDITORIAL:     editor#na-biz.com

PARTNERSHIP:     biz#na-biz.com

HUMAN RESOURCE:     hr#na-biz.com

* (replace # with @)

  • Official Site

Copyright © NORTH AMERICAN BUSINESS All rights reserved.

No Result
View All Result
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

Copyright © NORTH AMERICAN BUSINESS All rights reserved.